Exendin-(9-39) is an inverse agonist of the murine glucagon-like peptide-1 receptor: Implications for basal intracellular cyclic adenosine 3',5'-monophosphate levels and β-cell glucose competence

Endocrinology

Volumn 139, Issue 11, 1998, Pages 4448-4454

  Serre, Véronique ^a   Dolci, Wanda ^a   Schaerer, Elizabeth ^a   Scrocchi, Louise ^c   Drucker, Daniel ^c   Efrat, Shimon ^b   Thorens, Bernard ^a,d  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d University of Lausanne Departement de Pharmacologie et de Toxicologie   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; EXENDIN; GLUCAGON LIKE PEPTIDE 1; GLUCAGON RECEPTOR; GLUCAGON RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; DRUG EFFECT; EXOCYTOSIS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HORMONE RESPONSE; INSULIN LIKE ACTIVITY; INSULIN RELEASE; LIGAND BINDING; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; POSTPRANDIAL STATE; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

EID: 0031789874     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.139.11.6295     Document Type: Article

References (31)

1. Creutzfeld W, Ebert W, Nauck M, Stöckmann F 1983 Disturbances of the entero-insular axis. Scand J Gastroenterol [Suppl| 83:111-119
2. Göke R, Fehmann H-C, Göke B 1991 Glucagon-like peptide-1 (7-36) is a new incretin/enterogastrone candidate. Eur J Clin Invest 21:135-144
3. Göke R, Conlon JM 1988 Receptors for glucagon-like peptide-1(7-36)amideon rat insulinoma-derived cells. J Endocrinol 116:357-362
4. Thorens B 1992 Expression cloning of the pancreatic beta cell receptor tor the gluco-incretin hormone glncagon-like peptide I. Proc Natl Acad Sci USA 89:8641-8645
5. Usdin TB, Mezey E, Button DC, Brownstein MJ, Bonner TI 1993 Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain. Endocrinology 133:2861-2870
6. Thorens B 1994 The gluco-incretin hormone glucagon-like peptide-1 and its β cell receptor. In: Draznin B, LeRoith D (eds) Molecular Biology of Diabetes, part 1. Humana Press, Totowa, pp 357-379
7. Thorens B, C. Widmann 1996 Structure and function of the glucagon-like peptide-1 receptor. In: Lefèbvre I'J (ed) Glucagon III. Springer, Berlin, pp 255-273
8. Ämmälä C, Ashcroft FM, Rorsman P 1993 Calcium-independent potentiation of insulin release by cyclic AMP in single βcells. Nature 363:356-358
9. Schuit FC, Pipeleers DG 1985 Regulation of 3′,5′-monophosphate levels in the pancreatic B cell. Endocrinology 117:834-840
10. Gremlich S, Porret A, Hani E-H, Cherif D, Vionnet N, Froguel P, Thorens B 1995 Cloning, functional expression and chromosomal localisation of the human pancreatic islet glucose-dependent insulinotropic polypeptide receptor. Diabetes 44:1202-1208
11. Moens K, Heimberg H, Flamez D, Huypens P, Ling Z, Pipeleers D, Gremlich S, Thorens B, Schuit F 1996 Expression and functional activity of glucagon, glucagon-like peptide-1, and glucose-dependent insulinotropic peptide receptors in rat pancreatic islet cells. Diabetes 45:257-261
12. Abrahamsen N, Nishimura E 1995 Regulation of glucagon and glucagon-like peptide-1 receptor messenger ribonucleic acid expression in cultured rat pancreatic islets by glucose, cyclic adenosine 3′,5′-monophosphate, and glucocorticoids. Endocrinology 136:1572-1578
13. Efrat S, Fusco-DeMane D, Lemberg H, Al Emran O, Wang X 1995 Conditional transformation of a pancreatic β-cell line derived from transgenic mice expressing a tetracycline-regulated oncogene. Proc Natl Acad Sci USA 92:3576-3580
14. Scrocchi LA, Brown TJ, MacLusky N, Brubaker PL, Auerbach AB, Joyner AL, Drucker DJ 1996 Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide-1 receptor gene. Nat Med 2:1254-1258
15. Efrat S, Linde S, Kofod H, Spector D, Delannoy M, Grant S, Hanahan D, Baekkeskov S 1988 Beta-cell lines derived from tansgenic mice expressing a hybrid insulin gene-oncogene. Proc Natl Acad Sci USA 85:9037-9041
16. Widmann C, Bürki E, Dolci W, Thorens B 1994 Signal transduction by the cloned glucagon-like peptide-1 receptor. Comparison with signalling by the endogenous receptors of βcell lines. Mol Pharmacol 45:1029-1035
17. Bozou JC, Amar S, Vincent JP, Kitabgi P 1986 Neurotensin-mediated inhibition of cyclic AMP formation in neuroblastoma N1E115 cells: involvement of the inhibitory GTP-binding component of adenylate cyclase. Mol Pharmacol 29:489-496
18. Chomczynski P, Sacchi N 1987 Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159
19. Heinrich G, Gros P, Lund PK, Bentley RC, Habener JF 1984 Pre-proglucagon messenger ribonucleic acid: nucleotido and encoded amino acid sequences of the rat pancreatic complementary deoxyribonucleic acid. Endocrinology 115:2176-2181
20. Eng J, Kleinman WA, Singh L, Singh G, Raufman J-P 1992 Isolation and characterization of exendin-4, an exendin-3 analogue, from heloderma suspectum venom. Further evidence tor an exenclin receptor tin dispersed acini from guinea pig pancreas. J Biol Chem 267:7402-7405
21. Creutzfeld W, Nauck M 1992 Gut hormones and diabetes mellitus. Diabetes Metab Rev 8:149-177
22. Thorens B, Porret A, Bühler L, Deng S-P, Morel P, Widmann C 1993 Cloning and functional expression of the human islet GLP-1 receptor. Demonstration that exendin-4 is an agonist and exendin-(9-39) an antagonist of the receptor. Diabetes 42:1678-1682
23. Kolligs F, Fehmann H-C, Göke R, Göke B 1995 Reduction of the incretin effect in rats by the glucagon-like peptide 1 receptor antagonist exendin (9-39) amide. Diabetes 44:16-19
24. Wang Z, Wang RM, Owji AA, Smith DM, Ghatei MA, Bloom SR 1995 Glucagon-like peptide-1 is a physiological incretin in rat. J Clin Invest 95:417-421
25. D'Alessio DA, Vogel R, Prigeon R, Laschansky E, Koerker E, Eng J, Ensinck JW 1996 Elimination of the action of glucagon-like peptide 1 causes an impairment of glucose tolerance after nutrient ingestion by healthy baboons. J Clin Invest 97:133-138
26. Marie J-C, Boissard C, Skoglund G, Rosselin G, Breant B 1996 Glucagon acts through its own receptor in the presence of functional glucagon-like peptide-1 receptors on hamster insulinoma. Endocrinology 137:4108-4114
27. Samama P, Pei G, Costa T, Cotecchia S, Lefkowitz RJ 1994 Negative antagonists promote an inactive conformation of the β2-adrenergic receptor. Mol Pharmacol 45:390-394
28. Chidiac P, Hebert TE, Valiquette M, Dennis M, Bouvier M 1994 Inverse agonist activity of the β-adrenergic receptor. Mol Pharmacol 45:490-499
29. Costa T, Herz A 1989 Antagonists with negative intrinsic activity at the δ opioid receptors coupled to GTP-binding proteins. Proc Natl Acad Sci USA 86:7321-7325
30. Milligan G, Bond RA, Lee M 1995 Inverse agonism: pharmacological curiosity or potential therapeutic strategy? Trends Pharmacol Sci 16:10-13
31. Milano CA, Allen LF, Rockman HA, Dolber PC, McMinn TR, Chien KR, Johnson TD, Bond RA, Lefkowitz RJ 1995 Enhanced myocardial function in transgenic mice overexpresstng the β2-adrenergic receptor. Science 264: 582-586